# Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy

> **NCT00956644** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 406 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** irbesartan/amlodipine
- **DRUG:** amlodipine

## Key facts

- **NCT ID:** NCT00956644
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 406 (ESTIMATED)
- **Last updated:** 2010-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956644, "Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00956644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*